Results 41 to 50 of about 677,625 (318)

Effects of Coloring Food Images on the Propensity to Eat: A Placebo Approach With Color Suggestions

open access: yesFrontiers in Psychology, 2020
BackgroundResearch findings on the appetite-enhancing effect of the color red and the appetite-reducing effect of blue have been inconsistent. The present study used a placebo approach and investigated whether verbal suggestions can enhance color ...
Carina Schlintl, Anne Schienle
doaj   +1 more source

The ‘placebo effect’ in the conservative treatment of plantar fasciitis: a systematic review and meta-analyses

open access: yesEFORT Open Reviews, 2023
Purpose: The study of the placebo effect is key to elucidate the ‘real effect’ of conservative interventions for plantar fasciitis. The aim of this meta-analysis was to quantify the impact of placebo in the different conservative treatments of plantar ...
Valentina Viglione   +5 more
doaj   +1 more source

Improved 1000-m Running Performance and Pacing Strategy With Caffeine and Placebo: A Balanced Placebo Design Study. [PDF]

open access: yes, 2019
Purpose: To investigate the placebo effect of caffeine on pacing strategy and performance over 1000-m running time trials using a balanced placebo design.
Roelands, Bart   +9 more
core   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold   +12 more
wiley   +1 more source

Deep Brain Stimulation for Chronic Facial Pain: An Individual Participant Data (IPD) Meta-Analysis

open access: yesBrain Sciences, 2023
Despite available, advanced pharmacological and behavioral therapies, refractory chronic facial pain of different origins still poses a therapeutic challenge.
Hebatallah Qassim   +7 more
doaj   +1 more source

Rethinking placebo in psychiatry: How and why placebo effects occur

open access: yes, 2013
This article outlines proximate (physical and mental) and ultimate mechanisms of placebo effects. Interpersonal processes contributing to placebo effects are reviewed and illustrated through research into the process of psychotherapy.
St John-Smith, Paul   +3 more
core   +1 more source

No differences between beetroot juice and placebo on competitive 5-km running performance: A double-blind, placebo-controlled trial [PDF]

open access: yes, 2020
We examined the effect of beetroot juice on endurance running performance in “real-world” competitive settings. One-hundred recreational runners (54% male; mean ± standard deviation, age = 33.3 ± 12.3 years, training history = 11.9 ± 8.1 years, hours per
Hurst, P., Coleman, D., Saunders, S.
core   +1 more source

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket   +14 more
wiley   +1 more source

Clinical Efficacy of Prolotherapy for Temporomandibular Joint Disorders: A Systematic Review and Meta-Analysis

open access: yesClinics and Practice
Background: Temporomandibular disorders (TMDs) encompass a group of conditions characterized by anatomical, histological, and/or functional abnormalities that affect the muscular and/or articular components of the temporomandibular joint. Prolotherapy is
Antonios Saramantos   +6 more
doaj   +1 more source

AVURT: aspirin versus placebo for the treatment of venous leg ulcers – a Phase II pilot randomised controlled trial

open access: yesHealth Technology Assessment, 2018
Background: Venous leg ulcers (VLUs) are the most common cause of leg ulceration, affecting 1 in 100 adults. VLUs may take many months to heal (25% fail to heal). Estimated prevalence is between 1% and 3% of the elderly population.
Helen Tilbrook   +21 more
doaj   +1 more source

Home - About - Disclaimer - Privacy